PET Scans: A High-Tech Look Inside Your Body
PET scans can still be very helpful for both you and your doctor. If you have any questions or concerns about PET scans, or if you’re thinking about having one, it’s always a good idea to talk to your doctor. They can give you more information and help you make a decision about whether a PET scan is the right choice for you.
PET Scan vs. CT Scan: What’s the Difference?
Both PET scans and CT scans are useful methods for diagnosing medical conditions. PET scans are particularly helpful for identifying and diagnosing cancer as well as other conditions like heart disease and brain disorders because they have the unique advantage of being able to provide functional information about the body’s tissues and organs. PET scans are an important tool in the field of medical imaging, despite having some drawbacks and perhaps not being as widely or inexpensively available as CT scans.
PET Scan vs. MRI: What’s the Difference?
Both PET scans and MRI are beneficial medical imaging techniques, but they each have particular benefits and drawbacks. While MRI is particularly useful for creating detailed images of the body’s soft tissues and has the ability to image the body in multiple planes, PET scans are particularly useful for providing functional information about the body’s tissues and organs and are highly sensitive and accurate. The most thorough and precise diagnosis and treatment plan may every once in a while, be produced by combining PET and MRI.
PET tracer may improve understanding of Alzheimer’s Disease
This new PET tracer compound, SMBT-1, focuses on astrocytes, which are the most abundant cell type in the brain, even more abundant than neurons. The tracer is able to selectively detect activated astrocytes, which may be a marker of undesirable brain inflammation which precedes cognitive deterioration.
PET/CT predicts survival outcomes in immunotherapy patients
Article: https://www.auntminnie.com/index.aspx?sec=sup&sub=mol&pag=dis&itemId=134558 In this study of 51 patients with melanoma on immunotherapy, the results of a PET/CT scan with the radiolabeled sugar molecule FDG, within the first few months after starting the treatment, predicted 3 and 5 year survival rates. Why is this important? If physicians know early that a patient is not responding adequately […]